MannKind (NASDAQ:MNKD) Releases Quarterly Earnings Results,

MannKind (NASDAQ:MNKD – Get Free Report) announced its quarterly earnings results on Tuesday. The biopharmaceutical company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.03, Briefing.com reports. The company had revenue of $51.20 million for the quarter, compared to the consensus estimate of $50.73 million. The company’s quarterly […]

Related Keywords

United States , Wisconsin , American , Michael Castagna , David Thomson , Securities Exchange Commission , Ameritas Investment Partners Inc , American Century Companies Inc , American International Group Inc , Cantor Fitzgerald , Mannkind Corporation , Get Free Report , Exchange Commission , Investment Partners , Wisconsin Investment Board , International Group , American Century Companies , Century Companies , Kind Corporation , Mannkind Daily , Mannkind , Nasdaq Mnkd , Mnkd , Medical , 56400p20 , Earnings ,